Related Articles
Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells
YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
Survivin selective inhibitor YM155 promotes cisplatin‑induced apoptosis in embryonal rhabdomyosarcoma
Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma